Seroprevalence of human immunodeficiency virus (HIV) infection among tuberculosis patients in Tamil Nadu

Indian Journal of Medical Research

Volumn 118, Issue OCT., 2003, Pages 147-151

  Ramachandran, R ^a   Datta, M ^a   Subramani, R ^a   Baskaran, G ^a   Paramasivan, C N ^a   Swaminathan, S ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

HIV seroprevalence; Mycobacterium tuberculosis; Tamil Nadu; Tuberculosis patients

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD SAMPLING; DRUG INDICATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MICROSCOPY; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT COUNSELING; POPULATION RESEARCH; PREVALENCE; SEROLOGY; SEROPREVALENCE; SEX DIFFERENCE; SPUTUM CULTURE; SPUTUM EXAMINATION; SPUTUM SMEAR; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; FEMALE; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; INDIA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 0346896552     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Global AIDS Surveillance Part I. Wkly Epidemiol Rec 2000; 40 : 379-83.
2. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282 : 677-86.
3. Telzak EE. Tuberculosis and human immunodeficiency virus infection. Med Clin North Am 1997; 81 : 345-60.
4. Estimation of HIV infection among adult population - HIV estimates for year 2001. HIV/AIDS - Indian scenario. NACO website accessed on 21.11.2002. (www.naco.nic.in).
5. Swaminathan S, Ramachandran R, Baskaran G, Paramasivan CN, Ramanathan U, Venkatesan P, et al. Risk of development of tuberculosis in HIV-infected patients. Int J Tuberc Lung Dis 2000; 4 : 839-44.
6. Kaur A, Babu PG, Jacob M, Narasimhan C, Ganesh A, Saraswathi NK, et al. Clinical and laboratory profile of AIDS in India. J Acquir Immune Defic Syndr 1992; 5 : 883-9.
7. Sharma SK, Saha PK, Dixit Y, Siddarmaiah NH, Seth P, Pande JN. HIV seropositivity among adult tuberculosis patients in Delhi. Indian J Chest Dis Allied Sci 2000; 42 : 157-60.
8. Talib SH, Bansal MP, Kamble MM. HIV-1 seropositivity in pulmonary tuberculosis (study of 340 cases from Marathwada). Indian J Pathol Microbiol 1999; 36 : 383-8.
9. Paranjape RS, Tripathy SP, Menon PA, Mehendale SM, Khelavkar P, Joshi DR, et al. Increasing trend of HIV seroprevalence among pulmonary tuberculosis patients in Pune, India. Indian J Med Res 1997; 106 : 207-11.
10. Tripathy S, Joshi DR Mehendale SM, Menon P, Joshi AN, Ghorpade SV, et al. Sentinel surveillance for HIV infection in tuberculosis patients in India. Indian J Tuberc 2002; 49 : 17-20.
11. Jain NK, Aggarwal JK, Chopra KK, Khanna SP, Prevalence of HIV infection among tuberculosis patients. Indian J Tuberc 1996; 43 : 105.
12. Deo S. Prevalence of HIV infection in patients with tuberculosis. Indian J Tuberc 1995; 42 : 183.
13. Solomon S, Anuradha S, Rajasekaran S. Trend of HIV infection in patients with pulmonary tuberculosis in south India. Tuberc Lung Dis 1995; 76 : 17-9.
14. Vasadevaiah V. HIV infection among tuberculosis patients. Indian J Tuberc 1997; 44 : 97-8.
15. HIV seroprevalence in India-Indian scene 2001. NACO website. Accessed on 21.12.2002. (www.naco.nic.in).
16. Ramachandran R, Datta M, Shanmugam S, Bhaskar G, Subramanian R, Rawoof A, et al. The sero-prevalence of HIV infection among the tuberculosis patients. Int J Tuberc Lung Dis 1998; 2 : 438.
17. Petroff SA. A new and rapid method for the isolation and cultivation of tubercle bacilli directly from the sputum and feces. J Exp Med 1915; 21 : 38-42.
18. Kubica GP, Kent PT. Public Health Mycobacteriology: A Guide for the Level III Laboratory. Atlanta : US Department of Health & Human Services CDC, 1985; p. 159-84.
19. Joint United Nations Programme on HIV/AIDS (UNAIDS-WHO). Recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol Rec 1997; 72 : 81-7.
20. Jacob M, John TJ, George S, Rao PSS, Babu PG. Increasing prevalence of human immunodeficiency virus infection among patients attending a clinic for sexually transmitted diseases. Indian J Med Res 1995; 101 : 6-9.
21. Thappa DM, Singh S, Singh A. HIV infection and sexually transmitted diseases in a referral STD centre in south India. Sex Transm Infect 1999; 75 : 191-2.
22. Rajasekaran S, Uma A, Kamakshi S, Jeyaganesh D, Senthamizchelvan A, Savithri S, et al. Trend of HIV infection in patients with tuberculosis in rural south India. Indian J Tuberc 2000; 47 : 223-6.
23. Smith RL, Yew K, Berowitz KA, Aranda CP. Factors affecting the yield of acid-fast sputum smears in patients with HIV and tuberculosis. Chest 1994; 106 : 684-6.
24. Badri M, Ehrlich R, Pulerwitz T, Wood R, Maartens G. Tuberculosis should not be considered an AIDS-defining illness in areas with a high tuberculosis prevalence. Int J Tuberc Lung Dis 2002; 6 : 231-7.
25. Paramasivan CN, Bhaskaran K, Venkataraman P, Chandrasekharan V, Narayanan PR. Surveillance of drug resistance in tuberculosis in Tamil Nadu, India. Indian J Tuberc 2000; 47 : 27-33.
26. Revised National Tuberculosis control Programme. Technical Guidelines for Tuberculosis Control. Central Tuberculosis Division, Directorate General of Health Services, Ministry of Health and Family Welfare; July 1999.